Erste Asset Management GmbH Has $26.69 Million Position in Vertex Pharmaceuticals Incorporated $VRTX

robot
Abstract generation in progress

Erste Asset Management GmbH reduced its stake in Vertex Pharmaceuticals (NASDAQ:VRTX) by 8.6% in the third quarter, now holding 67,517 shares valued at $26.69 million. Other institutional investors have also adjusted their positions in the pharmaceutical company. Despite a slight EPS miss in Q4 earnings, analysts maintain a “Moderate Buy” rating for VRTX, with an average target price of $542.00, though significant insider selling was noted.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
0/400
No comments
  • Pin

Trade Crypto Anywhere Anytime
qrCode
Scan to download Gate App
Community
English
  • 简体中文
  • English
  • Tiếng Việt
  • 繁體中文
  • Español
  • Русский
  • Français (Afrique)
  • Português (Portugal)
  • Bahasa Indonesia
  • 日本語
  • بالعربية
  • Українська
  • Português (Brasil)